CA Patent

CA2212257A1 — Contrast media for in vivo imaging based on light transmission on reflection

Assigned to GE Healthcare AS · Expires 1996-08-08 · 30y expired

What this patent protects

The present invention relates to the use of particulate materials as contrast agents in in vivo light imaging.

USPTO Abstract

The present invention relates to the use of particulate materials as contrast agents in in vivo light imaging.

Drugs covered by this patent

Spy Agent Green Kit (INDOCYANINE GREEN) · Renew Pharms

Patent Metadata

Patent number: CA2212257A1
Jurisdiction: CA
Classification: —
Expires: 1996-08-08
Drug substance claim: No
Drug product claim: No
Assignee: GE Healthcare AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.